- Min.Order :1 Kilogram
- Purity: 99%
- Payment Terms : L/C,D/A,D/P,T/T,Other
Keywords
Exemestane manufacturer 107868-30-4 Exemestane supplier
Quick Details
- Appearance:White to beige
- Application:Local anesthetic; Pharmaceutical intermediate; Research chemical
- PackAge:25KG/DRUM
- ProductionCapacity:10000|Kilogram|Year
- Storage:2-8°C
- Transportation:General cargo transport
Superiority:
Hanways Chempharm Co., Limited, the former is Hubei Hanways Pharchem CO.,Limited, set up in 2009 in Wuhan, China. We specialize in sourcing and supplying APIs, pharmaceutical intermediates, and fine chemicals for worldwide markets.
The founder has decades experience in pharmaceutical industry. We are not just a trading company, but a comprehensive solutions supplier. With our sound knowledge of pharmaceutical business, to integrate resource and adapt to all different demands of markets is our advantage. We are a small but dynamic and energetic company with high efficient and high flexible decision making system.
Our products cover oncology APIs and intermediates, antiviral APIs and intermediates, cardiovascular APIs and intermediates, hormones APIs and intermediates and so on. Cater to the developing of pharmaceutical industry, we focus on the niche and new compounds.
Our business philosophy is customer-oriented, reliability and trustworthy, better service and win-win. We will take every effort to supply quality products to seek mutual development and benefits.
Details:
Brief Description
|
Product name |
Exemestane |
|
Synonyms |
Exemestan; 6-Methylenandrosta-1,4-diene-3,17-dione; 10,13-Dimethyl-6-methylidene-7,8,9,10,11,12,13,14,15,16-decahydrocyclopenta[a]phenanthrene-; 6-methylideneandrosta-1,4-diene-3,17-dione; (8ξ,9ξ,14ξ)-6-methylideneandrosta-1,4-diene-3,17-dione; Exemestane(Aromasin); Exemestone |
|
MOQ |
25KG |
|
CAS No. |
107868-30-4 |
|
Appearance |
An almost white powder |
|
Molecular Formula |
C20H24O2 |
|
Molecular Weight |
296.4034 |
|
Assay |
99% |
|
Application |
Pharma grade or research purpose |
|
Packing |
As per your request |
|
Storage |
Preserve in tight, light-resistant containers in a cool place |
|
Remarks |
NA |
|
Custom synthesis |
Available |
|
Supply Ability |
10000kg/month |
Medical use
Exemestane is indicated for the adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to it for completion of a total of five consecutive years of adjuvant hormonal therapy. US FDA approval was in October 2005.
Exemestane is also indicated for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.
Our Factory:
You Might Also Like
Related Searches
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View